Abstract:Crocin is a carotenoid-derived natural product found in the stigma of Crocus spp., which has great potential in medicine, food and cosmetics. In recent years, microbial production of crocin has drawn increasing attention, but there were no reports of successful implementation. Escherichia coli has been engineered to produce various carotenoids, including lycopene, β-carotene and astaxanthin. Therefore, we intended to construct E. coli cell factories for crocin biosynthesis. In this study, a heterologous crocetin and crocin synthesis pathway was first constructed in E. coli. Firstly, the three different zeaxanthin-cleaving dioxygenases CsZCD, CsCCD2 from Crocus sativus, and CaCCD2 from Crocus ancyrensis, as well as the glycosyltransferases UGT94E5 and UGT75L6 from Gardenia jasminoides, were introduced into zeaxanthin-producing E. coli cells. The results showed that CsCCD2 catalyzed the synthesis of crocetin dialdehyde. Next, the aldehyde dehydrogenases ALD3, ALD6 and ALD9 from Crocus sativus and ALD8 from Neurospora crassa were tested for crocetin dialdehyde oxidation, and we were able to produce 4.42 mg/L crocetin using strain YL4(pCsCCD2-UGT94E5-UGT75L6,pTrc-ALD8). Glycosyltransferases from diverse sources were screened by in vitro enzyme activity assays. The results showed that crocin and its various derivatives could be obtained using the glycosyltransferases YjiC, YdhE and YojK from Bacillus subtilis, and the corresponding genes were introduced into the previously constructed crocetin-producing strain. Finally, crocin-5 was detected among the fermentation products of strain YL4(pCsCCD2-UGT94E5-UGT75L6,pTrc-ALD8,pET28a-YjiC-YdhE-YojK) using HPLC and LC–ESI–MS. A heterologous crocin synthesis pathway was constructed in vitro, using glycosyltransferases from the Bacillus subtilis instead of the original plant glycosyltransferases, and a crocetin and crocin-5 producing E. coli cell factory was obtained. This research provides a foundation for the large-scale production of crocetin and crocin in E. coli cell factories.

Bioproduction of eriodictyol by Escherichia coli engineered co-culture

Systems Metabolic Engineering of Saccharomyces cerevisiae for the High-Level Production of (2S)-Eriodictyol

Engineering co-culture system for production of apigetrin in Escherichia coli

Biosynthesis of eriodictyol from tyrosine by Corynebacterium glutamicum

Heterologous erythromycin production across strain and plasmid construction

[Construction and optimization of ergothioneine-producing Escherichia coli]

Engineering Methyltransferase and Sulfoxide Synthase for High-Yield Production of Ergothioneine

Fermentative Production of Ergothioneine by Exploring Novel Biosynthetic Pathway and Remodulating Precursor Synthesis Pathways

Metabolic engineering and optimization of Escherichia coli co-culture for the de novo synthesis of genkwanin

De Novo Pterostilbene Production from Glucose Using Modular Coculture Engineering in Escherichia Coli.

Toward more efficient ergothioneine production using the fungal ergothioneine biosynthetic pathway

Enhancing Phycocyanobilin Production Efficiency in Engineered Corynebacterium glutamicum: Strategies and Potential Application.

Recent progress in therapeutic natural product biosynthesis using Escherichia coli

Optimization of fermentation conditions for the production of curcumin by engineered Escherichia coli

Optimized De Novo Eriodictyol Biosynthesis in Streptomyces albidoflavus Using an Expansion of the Golden Standard Toolkit for Its Use in Actinomycetes

Metabolically engineered Escherichia coli for efficient production of glycosylated natural products

De novo biosynthesis of complex natural product sakuranetin using modular co-culture engineering

Construction of Escherichia Coli Cell Factories for Crocin Biosynthesis

Engineering Escherichia coli coculture systems for the production of biochemical products

Engineering Saccharomyces cerevisiae coculture platform for the production of flavonoids.

High-Level Bio-Based Production of Coproporphyrin in Escherichia coli